Replimune (REPL) Amortization - Intangibles (2021 - 2022)
Replimune's (REPL) quarterly Amortization - Intangibles came in at $607000.0 in Q3 2022, little changed year-on-year from $607000.0 in Q3 2021, and little changed quarter-over-quarter from $607000.0 in Q2 2022.
Replimune (REPL) Amortization - Intangibles (2021 - 2022) Analysis & Trends
Replimune has disclosed Amortization - Intangibles across 2 years of filings, most recently posting $607000.0 for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 607,000.00 |
| Jun 30, 2022 | 607,000.00 |
| Sep 30, 2021 | 607,000.00 |
| Jun 30, 2021 | 607,000.00 |